Objective: The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) tool was designed to classify randomized clinical trials (RCT) as being more pragmatic or explanatory. We modified the PRECIS tool (called PRECIS-Review tool [PR-tool]) to grade individual trials and systematic reviews of trials. This should help policy makers, clinicians, researchers, and guideline developers to judge the applicability of individual trials and systematic reviews. Study Design and Setting: To illustrate the usefulness and applicability of the PR-tool, we applied it to two systematic reviews. Each included RCT was scored on the 10 PRECIS domains on a scale of 1-5. After this scoring, a 10-domain average for each individual trial and for the systematic ...
Abstract Background The pragmatic–explanatory continuum indicator summary version 2 (PRECIS-2) tool ...
Full list of author information is available at the end of the articleBackground Pragmatic and expla...
OBJECTIVE: To compare two approaches for trial teams to apply PRECIS-2 to pragmatic trials: independ...
Objective: The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) tool was designed to class...
OBJECTIVE: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool was designed to class...
Objective: To propose a tool to assist trialists in making design decisions that are consistent with...
Objective: To propose a tool to assist trialists in making design decisions that are consistent with...
Objectives: PRagmatic Explanatory Continuum Indicator Summary (PRECIS)-2 is a tool that could improv...
Abstract Background Numerous explanatory randomized t...
If you want to know which of two or more healthcare interventions is most effective, the randomised ...
Abstract Background There continues to be debate about what constitutes a pragmatic trial and how it...
OBJECTIVES:. To assess the pragmatism of published critical care randomized controlled trials self-d...
Background: If you want to know which of two or more healthcare interventions is most effective...
Abstract Introduction Pragmatic randomized controlled trials (RCTs) mimic usual clinical practice an...
OBJECTIVE: We refer to the effectiveness (known as pragmatic or real world) and efficacy (known as e...
Abstract Background The pragmatic–explanatory continuum indicator summary version 2 (PRECIS-2) tool ...
Full list of author information is available at the end of the articleBackground Pragmatic and expla...
OBJECTIVE: To compare two approaches for trial teams to apply PRECIS-2 to pragmatic trials: independ...
Objective: The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) tool was designed to class...
OBJECTIVE: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool was designed to class...
Objective: To propose a tool to assist trialists in making design decisions that are consistent with...
Objective: To propose a tool to assist trialists in making design decisions that are consistent with...
Objectives: PRagmatic Explanatory Continuum Indicator Summary (PRECIS)-2 is a tool that could improv...
Abstract Background Numerous explanatory randomized t...
If you want to know which of two or more healthcare interventions is most effective, the randomised ...
Abstract Background There continues to be debate about what constitutes a pragmatic trial and how it...
OBJECTIVES:. To assess the pragmatism of published critical care randomized controlled trials self-d...
Background: If you want to know which of two or more healthcare interventions is most effective...
Abstract Introduction Pragmatic randomized controlled trials (RCTs) mimic usual clinical practice an...
OBJECTIVE: We refer to the effectiveness (known as pragmatic or real world) and efficacy (known as e...
Abstract Background The pragmatic–explanatory continuum indicator summary version 2 (PRECIS-2) tool ...
Full list of author information is available at the end of the articleBackground Pragmatic and expla...
OBJECTIVE: To compare two approaches for trial teams to apply PRECIS-2 to pragmatic trials: independ...